** Shares of payments solutions provider PAYS.O rise 4% to
$2.57 premarket as D.A. Davidson upgrades to "buy" from
"neutral"
** Analyst Peter Heckmann, rated four out of five in
estimates accuracy on Refinitiv Eikon, expects an increase in
revenue and margins over the next six quarters as Paysign's two
primary businesses see volumes rebound
** Brokerage says decline in plasma collection volumes will
be temporary, though PAYS faced pressure on revenue and margins
in 2020
** D.A. Davidson expects "the operators of collection
centers to continue to raise the compensation per donation to
encourage donors to return given the importance of Plasma to the
medical field"
** Brokerage says Q2 results indicate that the donor
compensation market has started to rebound
** PAYS posted a 3.2% increase in Q2 revenue to $6.7 mln and
raised its FY adj. EBITDA forecast last week urn:newsml:reuters.com:*:nASA02ID1
** Of four brokerages, one rate the stock "strong buy", two
"buy" and one "hold" - Refinitiv data
(Reporting by Siddarth S)
((Siddarth.s@thomsonreuters.com;))